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ABSTRACT 
THE EFFECTS OF BORDETELLA PERTUSSIS ON DENDRITIC CELL IMPRINTING 
OF CD4+ T CELLS 
by Sana Waheed 
Bordetella pertussis is an aerobic gram-negative bacterial pathogen that causes 
the human respiratory disease whooping cough.  Despite widespread vaccination, 
whooping cough is reemerging due to decreased vaccine efficacy.  One of the hallmarks 
of infection is lymphocytosis, which is induced by the pertussis toxin.  Lymphocytes such 
as CD4+ T cells navigate to infected tissues through surface-trafficking molecules, which 
are imprinted during their interaction with tissue-associated dendritic cells.  We 
hypothesized that the pertussis toxin affects the imprinting process resulting in altered 
expression of trafficking molecules on CD4+ T cells.  We tested this hypothesis using a 
mouse model of infection.  Imprinting levels on CD4+ T cells were compared to 
Bordetella parapertussis, a related strain that lacks pertussis toxin.  Our results indicated 
that 5 days post-infection, the percentage of lung dendritic cells increased and adopted a 
mature phenotype (displaying an increased capability to migrate and present antigen to T 
cells) in response to B. pertussis infection, and there was an overall downregulation of 
trafficking molecules on CD4+ T cells.  However, 25 days post-infection with B. 
pertussis, dendritic cells continued to express elevated levels of MHC class II, and the 
expression of trafficking markers on CD4+ T cells also increased compared to uninfected 
controls.  These results enable identification of molecules that are specific for 
lymphocyte trafficking to the respiratory airways and contribute to knowledge useful in 
the development of better vaccines. 
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PREFACE 
This thesis is comprised of three chapters and the appendices.  Chapter I provides 
an overview of the research project and includes information regarding each part of the 
project.  The second chapter is presented in journal format according to the guidelines set 
by the Journal of Immunology.  The final chapter includes the conclusions from the 
research as well as a discussion of future directions.  The appendices provide additional, 
supplementary data associated with this study.  
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CHAPTER I 
INTRODUCTION 
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Overview of the Research Project 
Immune cells such as lymphocytes circulate between the blood, lymph nodes, and 
organs due to chemotactic interactions between secreted and surface molecules in tissues 
and surface molecules on immune cells.  This process is termed lymphocyte trafficking 
and is responsible for the recruitment of T lymphocytes to sites of infection (1).  
Lymphocyte trafficking (homing) to infected organs and tissues is crucial for the 
elimination of airborne pathogens and for restoration of a homeostatic environment such 
that unnecessary inflammation and tissue damage is prevented.  T lymphocytes are able 
to home to specific organs due to a special combinatorial pattern of surface trafficking 
molecules that are “imprinted” on their surface during interaction with dendritic cells.  
The trafficking molecules responsible for exclusive homing to the airways remain 
unknown.  We report here our study of CD4+ T cell trafficking using two respiratory 
pathogens, B. pertussis, which produces pertussis toxin and, B. parapertussis, which does 
not.  Pertussis toxin is responsible for lymphocytosis (extremely elevated levels of 
lymphocytes in the bloodstream) and is known to inhibit G proteins, which are 
responsible for cell signaling leading to chemotaxis or cell migration.  Therefore we 
designed this study to observe the effects of pertussis toxin on dendritic cell imprinting of 
trafficking molecules on CD4+ T cells that could lead to preventing their exit from the 
bloodstream and entry into the lungs.       
This project had two main objectives.  The first objective was to analyze the 
presence of homing molecules on CD4+ T cells in three different compartments (lymph 
nodes, blood, and lungs), which was conducted primarily by Brian Kwong.  Imprinting of 
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homing molecules occurs in the lymph nodes so it was important to include the CD4+ T 
cell trafficking levels in our analyses.  Levels of these molecules were also measured for 
CD4+ T cells in the blood and lungs to observe their phenotype after imprinting.  
Together the information from these tissues allowed us to compare the level of each 
trafficking marker in various compartments during experimental infection.  
The second objective of this project was to mimic the in vivo imprinting process 
that takes place in the lymph nodes, and observe the resulting interactions that occur 
between isolated lung dendritic cells and naïve allogeneic splenocytes in an in vitro co-
culture system.  The focus of this thesis was objective two of the overall research project, 
which should inform us about the effects of pertussis toxin on the ability of dendritic cells 
to imprint homing molecules on naïve T cells.  To study this process, a co-culture system 
was developed using isolated lung dendritic cells from uninfected and Bordetella-infected 
mice and co-cultured overnight with naïve splenocytes to allow for imprinting.  The 
expression levels of trafficking molecules on CD4+ T cells from uninfected and 
Bordetella-infected co-cultures were compared by flow cytometry.  These experimental 
results will contribute to our understanding of the pathogenesis of B. pertussis, as well as 
the role of imprinting molecules in respiratory trafficking of CD4+ T cells.  This 
knowledge may lead to improved vaccine development targeting molecules that 
participate in lung homing. 
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CHAPTER II 
THE EFFECTS OF BORDETELLA PERTUSSIS ON DENDRITIC CELL IMPRINTING 
OF CD4+ T CELLS 
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Abstract 
Bordetella pertussis is an aerobic gram-negative bacterial pathogen that causes 
the human respiratory disease whooping cough.  Despite widespread vaccination, 
whooping cough is reemerging due to decreased vaccine efficacy.  One of the hallmarks 
of infection is lymphocytosis, which is induced by the pertussis toxin.  Lymphocytes such 
as CD4+ T cells navigate to infected tissues through surface-trafficking molecules, which 
are imprinted during their interaction with tissue-associated dendritic cells.  We 
hypothesized that the pertussis toxin affects the imprinting process resulting in altered 
expression of trafficking molecules on CD4+ T cells.  We tested this hypothesis using a 
mouse model of infection.  Imprinting levels on CD4+ T cells were compared to 
Bordetella parapertussis, a related strain that lacks pertussis toxin.  Our results indicated 
that 5 days post-infection, the percentage of lung dendritic cells increased and adopted a 
mature phenotype (displaying an increased capability to migrate and present antigen to T 
cells) in response to B. pertussis infection, and there was an overall downregulation of 
trafficking molecules on CD4+ T cells.  However, 25 days post-infection with B. 
pertussis, dendritic cells continued to express elevated levels of MHC class II, and the 
expression of trafficking markers on CD4+ T cells also increased compared to uninfected 
controls.  These results enable identification of molecules that are specific for 
lymphocyte trafficking to the respiratory airways and contribute to knowledge useful in 
the development of better vaccines. 
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Introduction 
Bordetella pertussis is an aerobic gram-negative bacterium that causes the 
respiratory disease whooping cough in humans.  Considerable mortality was attributed to 
B. pertussis in the early twentieth century, which declined once a vaccine was introduced.  
However, whooping cough is reemerging in both adults and children due to drop in 
vaccine efficacy (2-3).  Vaccinated adults can be carriers of pertussis and manifest a 
prolonged, but relatively mild respiratory disease, which may be transmitted to 
unvaccinated infants (4).  In infants the manifestations can include vomiting, pneumonia, 
hypoxia, seizures or apnea.  Throughout the world there are 300,000 pertussis-related 
deaths each year, mostly in children (5).  Although these cases are mainly seen in 
developing areas of the world, there have been incidents of pertussis outbreaks in the 
United States and, according to the Centers for Disease Control and Prevention, the U.S. 
had over 10,000 reported cases of pertussis in 2007 (6).  The onset of the disease is 
characterized by a persistent, forceful whoop-like cough that can last for several weeks to 
months, even after the clearance of the bacteria. The hallmark of the disease is 
leukocytosis with extreme lymphocytosis, which is attributed to one of the bacterial 
virulence factors, pertussis toxin (PTx) (7-10).   
Bordetella pertussis is an extracellular pathogen that colonizes the upper 
respiratory system and bronchial epithelial cells.  The respiratory system is constantly 
exposed to airborne antigens.  The mucosal immunity maintains a steady state in which 
harmless antigens do not trigger unnecessary immune responses (11-12).  Tissue resident 
DCs sample the airways and are key players in supporting immunological tolerance in 
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response to non-pathogenic antigens (11).  Bordetella pertussis overcomes this 
suppressive mechanism and disrupts these homeostatic conditions in the airways.  Several 
bacterial factors contribute to the pathogenesis of B. pertussis in the respiratory tract.  
PTx is a secreted AB subunit exotoxin that is associated with numerous pathogenic 
functions and immunomodulation.  It is responsible for inhibiting chemotaxis in T cells, 
macrophages, neutrophils, and reduced B cell survival (13).  The A subunit is the 
enzymatically active component that is responsible for ADP-ribosylation and inhibition 
of the alpha subunit of G proteins (Gα) on target host cells (14).  G proteins are coupled 
to chemokine receptors and mediate cell signaling.  PTx prevents activation of Gα and 
interferes with signaling that leads to chemotaxis and cell migration (8, 15).  
Administration of soluble PTx was reported to delay the initial recruitment of immune 
cells such as neutrophils and macrophages, which are responsible for engulfing and 
killing bacteria (16-20).  Impaired neutrophil and macrophage function can lead to 
colonization of B. pertussis in the respiratory tract  
During respiratory infection, DCs sample and pinocytose (internalize) antigen 
from the tracheal lumen and tissue-penetrating antigens.  Immediately after antigen 
internalization, DCs develop a mature phenotype that is comprised of upregulation of 
surface maturation markers such as MHC class II, CD40, and CD86, which facilitate DC 
entry into the lymphatics and migration to the draining lymph nodes where antigen 
presentation to T cells occurs (21-23).  The interaction of mature DCs with naïve T cells 
in the lymph nodes results in T cell activation, signaling, and upregulation of trafficking 
receptors, a mechanism called imprinting.  Mature DCs derived from a specific tissue 
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will then imprint T cells with trafficking receptors that direct them to the area of infection 
where the antigen was originally encountered by the DC (24).  
Lymphocyte trafficking is a multi-step process that allows activated T cells to exit 
the lymph nodes, enter the bloodstream, extravasate, and home to infected tissue (1, 24-
26).  The first step of this process is a rolling/tethering action mediated by selectins that 
loosely bind the T cell to inflamed endothelium and slows its transit in the bloodstream.  
This is followed by attachment and activation of the T cell by chemokine receptors.  The 
third step is mediated by integrins, which completely halt the T cell in the bloodstream 
and mediate extravasation.      
The concept of trafficking receptor imprinting on lymphocytes is well 
documented in the gut and skin where the trafficking molecules and environmental 
factors influencing this interaction have been identified (26).  For example, DCs from gut 
origin imprint T cells in the presence of retinoic acid (a dietary environmental factor) 
with high levels of CCR9 and α4β7, which are the surface molecules that direct T cells to 
the small intestine (1, 25, 27-30).  Trafficking of T cells to the skin is mediated by DCs 
and activated Vitamin D3 derivatives that imprint CCR10, CLA, and CCR4, which leads 
T cells to the skin (1, 31-33).  As of now, the imprinting factors that direct T cell 
trafficking exclusively to the respiratory system have not been described (34). 
In this thesis, we studied the interactions between DCs and T cells during a 
respiratory infection with B. pertussis.  We hypothesized that B. pertussis (via PTx) alters 
DC imprinting of trafficking molecules on T cells.  This may lead to a high degree of 
lymphocytosis in the circulation with reduced levels of trafficking molecules that can 
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orient lymphocyte homing to the lungs.  We tested our hypothesis using B. pertussis and 
Bordetella parapertussis experimental infections in mice.  Bordetella parapertussis lacks 
PTx and was used as a control.  This comparison elucidated the effects of PTx on G 
protein-coupled receptor signaling, as well as DC and T cell interactions leading to T cell 
homing (35-36).  Since defective homing could lead to delayed clearance during B. 
pertussis infection, knowledge in this area should contribute to understanding the 
pathogenesis of this bacterium and aid in vaccine development based on lung associated 
trafficking molecules.   
  12 
 
 
 
 
Materials and Methods 
All studies using animals have been approved by the Institutional Animal Care and Use 
Committee (IACUC) (Protocol #921) at San José State University, San José, CA. 
 
Bacteria 
Two Bordetella strains were used, B. pertussis 338, which is a nalidixic acid-resistant 
derivative of the Tohama strain, and B. parapertussis, which was obtained from ATCC 
(#9305).  Both strains were grown on Bordet-Gengou blood plates, and single colonies 
were used to inoculate Stainer-Scholte broth containing Heptakis (Sigma-Aldrich, St. 
Louis, MO) prior to experimental infection. 
 
Experimental infection 
Six-week-old female Balb/c mice were inoculated intranasally with 20 µl of 5x106 colony 
forming units of B. pertussis or B. parapertussis.  Uninfected control mice received 20 µl 
of PBS (37-38).  Two time-points of experimental infection were established, 5 days 
post-infection (peak infection) and 25 days post-infection, which were determined by 
performing a time-course experiment where bacterial load in the lungs was measured for 
ten days and again on day 25 (see Appendix A).  To confirm infection and determine the 
bacterial load, lungs from experimentally infected mice were harvested, homogenized, 
and plated on Bordet-Gengou plates prior to each experiment.   
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Preparation of single cell suspensions from lungs and spleen 
Mice were exsanguinated followed by perfusion of lungs with 30-50 ml of PBS.  The 
lungs and trachea were removed, minced and digested in RPMI-1640, 10% FCS, 75U/ml 
DNase I (Sigma-Aldrich) and 250 U/ml Type I Collagenase (Worthington Biochemical 
Corporation, Lakewood, NJ) in a 37ºC orbital shaker for 45 to 60 minutes.  The digested 
lungs were passed through a 40-micron nylon mesh strainer and cells were washed with 
RPMI-1640 to remove residual digest medium.  Digested lung tissue was resuspended in 
40% Percoll (GE Lifescience, Piscataway, NJ), slowly underlaid with 70% Percoll and 
centrifuged for 25 minutes to create a density gradient.  Cells at the 40-70% interface 
(mononuclear cells) were collected and used for enrichment of DCs. The spleens from 
uninfected allogeneic mice were harvested and pressed through a nylon mesh to obtain a 
single cell suspension (39).  Splenocytes were incubated with 3 ml red blood cell lysis 
buffer (Sigma-Aldrich) for 5 minutes and washed with RPMI-1640 with 10% FCS.  Cell 
pellets from the lungs were resuspended in buffer (PBS, 0.5% FCS, 2 mM EDTA) 
suitable for MACS columns. 
 
Enrichment of lung DCs  
All cell enrichments were performed using magnetic microbeads (Miltenyi Biotech, 
Auburn, CA).  For DC enrichment from lungs, CD11c microbeads (N418) were used and 
lung mononuclear cells were enriched for CD11c+ cells using positive selection with a 
MiniMACS separator.  Briefly, lung mononuclear cells were incubated with 100 µl of 
CD11c microbeads for 15 minutes at 4°C.  Cells were washed with MACS buffer (PBS, 
  14 
 
 
 
 
0.5% FCS, 2 mM EDTA) and resuspended in 500 µl of buffer. One MS column was used 
to enrich for CD11c+ cells.   
 
T cell activation and co-cultures 
For co-culturing experiments, 24-well plates were coated with the purified monoclonal 
antibodies CD3 (1 µg/ml) and CD28 (1 µg/ml) in PBS, and incubated at 4ºC, as adapted 
from Sigmundsdottir (33) and Campanelli (39).  Enriched lung DCs were cultured with 
splenocytes from uninfected allogeneic mice at a 1:25 ratio in RPMI-1640 supplemented 
with 10% FCS, penicillin, streptomycin, IL-2 (12.5 ng/ml) and IL-12 (2.5 ng/ml) (R&D 
Systems, Minneapolis, MN).  Cells were co-cultured overnight at 37ºC with 5% CO2 to 
allow for imprinting, followed by flow cytometry analysis.  T cell activation was 
determined using intracellular antibody staining with Ki-67 (B56) and interferon γ 
(XMG1.2), which served as markers of T cell proliferation in an allogeneic system.  
Briefly, cells were stained for extracellular markers and resuspended in 250 µl 
Fixation/Permeabilization (BD Biosciences, Franklin Lakes, NJ) solution and incubated 
at 4°C for 20 minutes. Cells were washed twice with 1 ml of 1× Perm/Wash Buffer (BD 
Biosciences) and then resuspended in 100 µl of Perm/Wash Buffer containing the 
antibody or negative control. Cells were incubated at room temperature in the dark for 30 
minutes before being washed twice with 1 ml/wash of 1× Perm/Wash Buffer and 
resuspended in staining buffer (0.1% Sodium Azide, 1% FCS, PBS). 
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Flow cytometry 
Analysis of surface and intracellular markers was done by flow cytometry.  Lung derived 
DC phenotyping was measured by the expression of myeloid associated markers [CD11c 
(N418), CD11b (M1/70)] and maturation markers [MHC class II (M5/114.15.2), CD40 
(3/23), CD86 (GL-1)].  Additional trafficking markers were evaluated on DCs as detailed 
for T cells.  Expression of trafficking molecules on CD4+ T cells included CD4 (RM4-5, 
BD Biosciences and Invitrogen, Carlsbad, California), CD38 (90) and the following 
trafficking molecules: CD11a (M17/4), CD49f (GoH3), CD162 (2PH1, BD Biosciences), 
CXCR3 (220803, R&D Systems), CD49a (HMalpha1, ABDSerotec, Raleigh, NC), 
CD49d (9C10 MFR4.B), and CD103 (2E7).  All antibodies were purchased from 
BioLegend (San Diego, CA) unless otherwise indicated.  The levels of these markers 
were compared for B. pertussis and B. parapertussis infections and normalized to 
uninfected controls as explained in the figure legends.  Samples were acquired using the 
FACS Calibur (BD Biosciences) at San José State University and the LSRII (BD 
Biosciences) at Stanford University, and were analyzed using Flowjo. 
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Results 
Experimental design 
  Balb/c mice were inoculated intranasally with PBS (uninfected controls), B. 
pertussis or B. parapertussis for a period of 5 and 25 days.  At each time-point lungs 
were harvested, mononuclear cells were obtained and enriched for DCs (CD11c+ cells) 
using Miltenyi Microbeads (Fig. 1).  DCs were enumerated and phenotyped for each 
treatment using multicolor flow cytometry (Fig. 2, 4).  Imprinting of trafficking 
molecules was observed in co-cultures of lung DCs with naïve allogeneic splenocytes 
from Swiss Webster mice (Fig. 3, 5). 
 
Peak infection: DCs matured in response to Bordetella infection 
Five days post-infection we found 23% of CD11c+ cells in uninfected control 
lungs, whereas B. parapertussis had 33.1% and B. pertussis had 70.6% (Fig. 2A).  The 
percent DCs was estimated by the overall analysis of CD11c+ cells isolated from the 
lungs.  DC phenotype was characterized using CD11c+ and a second marker (Table I) 
using flow cytometry (Fig. 2B).  Levels of maturation markers were assessed with MHC 
class II, CD40, and CD86 (Fig C-D).  These molecules bind to the T cell receptor, 
CD40L, and CD28 respectively on CD4+ T cells, forming an immunological synapse that 
results in T cell activation and stimulation (11).  Since B. pertussis is an extracellular 
bacterial pathogen, we analyzed MHC class II, which is the molecule responsible for 
presenting antigen to CD4+ T cells.  Lung DCs from uninfected mice revealed low levels 
of MHC class II, CD40, and CD86 (7.72%, 10.64%, 6.11% respectively), whereas B. 
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parapertussis-infected DCs showed increased expression (20.64%, 13.67%, 14.04%).  
Comparatively, lung DCs from B. pertussis infection displayed the highest levels of 
maturation (64.92%, 36.64%, 60.26% respectively).   
The phenotypic marker CD11b is present on myeloid DCs of lung origin (40).  
Relatively low expression of CD11b (10.21%) was observed in lung DCs from 
uninfected control mice while this percentage increased in B. parapertussis infection 
(20.5%), but even more so in B. pertussis infection (61.04%).  Additionally, CCR5 was 
analyzed to observe DC migratory abilities to inflamed tissues.  There was low 
expression of CCR5 in uninfected DCs (7.76%) compared to B. parapertussis (13.95%,) 
and B. pertussis (55.84%).  Together, this data indicate that DCs mature during B. 
pertussis infection and do not appear to be inhibited by PTx. 
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FIGURE 1.  Experimental design.  Balb/c mice were infected and lungs were 
harvested 5 and 25 days post-infection.  Lungs were processed and mononuclear 
cells were obtained to further enrich for CD11c+ cells.  DCs were enumerated, 
phenotyped and analyzed for imprinting abilities in co-cultures with allogeneic 
splenocytes from Swiss Webster mice.  
Uninfected (PBS) B. pertussis B. parapertussis 
Time-points of 5 or 25 days  
post-infection 
Infect Balb/c 
mice on Day 0 
Harvest lungs and digest (separately) 
Obtain mononuclear cells with Percoll gradient 
Enrich for DCs using CD11c microbeads  
DC phenotyping using 
multicolor flow cytometry 
Imprinting of trafficking 
molecules from co-culture of 
lung DCs with allogeneic 
splenocytes from Swiss 
Websters 
Enumerate DCs with 
multicolor flow cytometry 
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TABLE I.  DC phenotypic markers.  The following markers were used to 
phenotype DCs and determine maturation levels for uninfected, B. pertussis 
and B. parapertussis infected lungs. 
 
 Marker  Function  
 CD11c  Expressed primarily on DCs 
 CD40  Co-stimulatory molecule 
 CD86  Co-stimulatory molecule 
 MHC class II   Extracellular antigen presentation molecule 
 CCR5  Allows DC migration to inflamed tissue (24) 
 CD11b  Integrin expressed on DCs and monocytes 
                        
  
 
 
  20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
FIGURE 2.  DC maturation 5 days post-infection with B. pertussis and B. parapertussis.  
Mononuclear cells were isolated from lungs and enriched for DCs.  Percent of CD11c+ 
cells was estimated using quadrants that were placed according to positive controls (A). 
Mononuclear cells were gated on monocytes, and doublets (cell clumping) were removed 
(B).  CD11c+ cells (DCs) were analyzed for a second phenotypic marker as detailed in C.  
(See Table I for a description of the markers).  For DC maturation, we measured levels of 
CD40, CD86, MHC class II; myeloid associated marker CD11b, as well as ability to 
migrate to lymph nodes with CCR5 (C-D).  Data are representative of at least 4 
independent experiments.      
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Infection with Bordetella alters trafficking receptor levels on naïve CD4+ T cells 
In order to verify the imprinting ability of lung DCs derived from experimentally 
infected mice, we co-cultured lung DCs with naïve splenocytes from allogeneic mice.  
Establishing an allogeneic system ensures that imprinting occurs on proliferating T cells, 
where DCs interact through MHC class II with the T cell receptor and trigger non-
specific T cell proliferation.  This leads to transcription of certain patterns of molecules 
that guide the T cell to the site of infection (33).  These homing molecules are a 
combination of chemokine receptors and integrins that interact with inflamed 
endothelium and allow transmigration of the T cell from the bloodstream into the tissue.   
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The proliferative nature of the allogeneic system was confirmed by intracellular 
staining for interferon γ (secreted during T cell activation) and Ki-67 (a nuclear factor of 
proliferation) in activated CD38+ cells (Fig. 3A).  A proliferating population was 
observed in each treatment; 0.5-1.8% of cells were positive for interferon γ and roughly 
2% were positive for Ki-67 indicating that we had a proliferating T cell system.  DC 
ability to imprint trafficking markers on allogeneic T cells was then analyzed.  Since little 
is known about specific lung homing markers, we analyzed a panel of trafficking 
molecules to determine whether the levels of imprinted homing molecules were altered in 
infected co-cultures compared to uninfected controls (Table 2).  Our results indicate an 
overall downregulation of homing molecules on CD4+ T cells during experimental B. 
pertussis infection compared to uninfected controls at 5 days post-infection.  These 
results were normalized to uninfected control values set at 100%.   
Recent studies indicate that CD11a, CD162, and CD103 are important markers 
for trafficking and cell retention in the lungs (28, 41-45).  On day 5 of infection, CD4+ T 
cells from B. parapertussis co-cultures showed upregulation of CD11a (125.9%) and 
CD162 (114.9%) but downregulation of CD103 (81.5%) compared to uninfected controls 
(100%) (Fig. 3C).  In contrast B. pertussis co-cultures showed downregulation of CD11a 
(94.4%) and CD162 (76.1%) with upregulation of CD103 (130.3%).  Additionally, the 
integrins CD49a and CD49d can dimerize with CD29 and have been reported to migrate 
to the respiratory system (21, 46-47).  However, downregulation was observed in both B. 
parapertussis and B. pertussis infections for CD49a (53.6%, 75.6% respectively) and 
CD49d (63.9%, 81.9% respectively) compared to uninfected controls (100%).  Another 
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adhesion molecule, CD49f, may play a role in lung homing and was downregulated more 
in B. pertussis co-cultures (69.9%) than in B. parapertussis (89.6%) (27).  There is also 
evidence in the literature that CXCR3 is involved in T cell homing to the lungs (11, 48-
50).  Five days post-infection with Bordetella, CXCR3 was downregulated in both B. 
parapertussis (49.6%) and B. pertussis (58.7%,) compared to uninfected controls (100%).  
 
 
 
 
 
TABLE II.  Trafficking markers and their functions.  A variety of markers that are 
implicated in the homing process were analyzed, such as molecules involved in tethering 
or rolling and other integrins that mediate attachment to the endothelium and lead to 
extravasation. 
  
 
 Marker   Function  Receptor Family 
 CD162 (PSGL-1)  Adhesion (43)  Selectin 
 CXCR3  Chemotaxis of T cells (49)  Chemokine receptor 
 CD11a (LFA-1)  Cell adhesion, costimulation (45)  Integrin 
 CD49a (α1)  Involved in T cell adhesion (46)  Integrin 
 CD49d (α4)  Cell migration, adhesion, homing (47)  Integrin 
 CD49f (α6)  Cell adhesion, migration (27)  Integrin 
 CD103 (αε)  Tissue retention of lymphocytes (42)  Integrin 
 CD38  Activation marker  --- 
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FIGURE 3.  Imprinting of trafficking molecules, 5 days post-infection, occurs when DCs 
interact with CD4+ T cells.  Lung DCs were cultured with naïve allogeneic splenocytes 
to allow for imprinting.  Intracellular flow cytometry was used to confirm that co-cultures 
were an allogeneic system using CD38 with Ki-67 and interferon γ (A).  For co-culture 
experiments flow cytometry was used to gate on the lymphocytes, doublets (cell 
clumping) were removed and CD4+ cells were identified to determine the pattern of 
trafficking receptors (B).  In order to observe whether imprinting occurred, levels of the 
chemokine receptor CXCR3 and various integrins (CD11a, CD162, CD49f, CD49a, 
CD49d, and CD103) were measured (C).  (See Table II for a description of the markers).  
Data was normalized to uninfected controls (100%) and are representative of at least 4 
independent experiments. 
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Twenty-five days post-infection: DC maturation levels decrease except for some markers 
in B. pertussis infection 
 In our previous experiment for 5 days post-infection, we observed an increase in 
both percent CD11c+ cells and DC maturation levels during experimental Bordetella 
infection.  In order to establish the phenotypic state of DCs 25 days post-infection, lungs 
were harvested and lung mononuclear DCs were isolated.  In the lungs, the percent gated 
CD11c+ cells decreased for B. pertussis (20.7%) and B. parapertussis (23.1%) infections 
to levels similar to uninfected controls (20.4%) (Fig. 4A).  DC phenotypic levels were 
then analyzed where lung DCs from B. parapertussis infection had reduced expression of 
the maturation marker CD86 (4.14%) compared to B. pertussis (8.04%) (Fig. 4B).  In 
contrast, MHC class II remained upregulated in B. pertussis (18.3%) whereas the levels 
for uninfected controls and B. parapertussis decreased to 6.74% and 7.57% respectively.   
The lung-associated marker CD11b was 5.24% for lung DCs from uninfected 
controls, whereas DCs from B. pertussis infection had elevated levels (13.1%) while DCs 
from B. parapertussis were downregulated (6.56%).  The DC migratory marker CCR5 
was upregulated on DCs from B. pertussis (7.24%) compared to B. parapertussis (3.59%) 
and uninfected controls (3.75%).  Together, this indicates that the effect of Bordetella on 
DC phenotype diminished 25 days post-infection with the exception of B. pertussis 
infection where MHC class II, CD86, CD11b, and CCR5 remained elevated.  
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FIGURE 4.  DC maturation 25 days post-infection with B. pertussis and B. 
parapertussis. After 25 days of infection lung mononuclear cells were obtained, enriched 
for DCs and gated similarly to that shown in Fig. 2B.  We assessed the percent CD11c+ 
cells in each treatment (as determined using quadrants from flow cytometry dot plots) (A) 
and evaluated DC maturation with MHC class II, CD40, CD86; myeloid and lung 
associated markers CD11b, CD11c, and migratory capability with CCR5 (B).  Data are 
representative of at least 3 independent experiments.   
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Trafficking receptor levels decreased in B. parapertussis co-cultures but increased in B. 
pertussis co-cultures 25 days after infection 
Intracellular flow cytometry results of interferon γ and Ki-67 confirmed the 
proliferative ability of each co-culture, as illustrated by the interferon γ positive and Ki-
67 positive populations (Fig. 5A).  The level of trafficking receptors on CD4+ T cells was 
measured to determine whether DCs continued to actively imprint 25 days post-infection.  
In B. pertussis-infected co-cultures, the adhesion and lung retention marker CD11a was 
upregulated to 201.1% whereas it was downregulated in B. parapertussis-infected co-
cultures (113.5%) when compared to uninfected controls (100%) (Fig. 5B).   
The integrins CD49d and CD49f are associated with migration and had reduced 
expression in B. parapertussis co-cultures (96.7% and 95.1% respectively) when 
compared to B. pertussis co-cultures, which displayed elevated levels of CD49d (164.6%) 
but maintained downregulation of CD49f (50.5%).  For B. pertussis co-cultures, CXCR3 
remained downregulated (21.4%) compared to uninfected controls (100%).  This suggests 
that 25 days post-infection, B. pertussis-infected DCs can imprint some trafficking 
molecules on CD4+ T cells, while this is not the case for B. parapertussis-infected co-
cultures, where these molecules are expressed at low levels. 
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FIGURE 5.  The levels of trafficking molecules increase 25 days post-infection in B. 
pertussis infection.  Lung DCs were cultured with naïve splenocytes overnight to allow 
for imprinting.  Intracellular staining with interferon γ and Ki-67 was included to confirm 
that imprinting occurred in the allogeneic co-cultures (A).  To determine the levels of 
imprinted markers, we gated on the lymphocytes, removed doublets (cell clumping), and 
identified trafficking markers on CD4+ cells (gating similar to that shown in Fig. 3B).  
On day 25 of infection we measured levels of lung retention molecules (CD11a, CD162, 
CD103), integrins (CD49a, CD49d, CD49f), and the chemokine receptor CXCR3 (B).  
All values were normalized to uninfected controls (100%).  Data are representative of at 
least 3 independent experiments.   
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Discussion 
Unlike other areas of the body such as the skin and gut where specific homing 
molecules that govern lymphocyte trafficking have been established (26), a unique 
trafficking molecule pattern to the respiratory airways remains to be defined.  We were 
interested in elucidating the role PTx has on DC imprinting of trafficking molecules on 
CD4+ T cells that guides them to the respiratory system.  PTx inhibits G protein 
activation and hinders chemotaxis of cells (8, 13, 15). Therefore, we established an 
experimental respiratory infection model using two bacteria from the Bordetella species: 
B. pertussis (produces PTx) and B. parapertussis (lacks PTx).   
DC origin and their level of maturation are critical components for imprinting. 
Therefore, we utilized flow cytometry to determine DC phenotype for uninfected controls 
and Bordetella-infected DCs.  At 5 days post-infection, CD11c+ cells increased 1.4 times 
in B. parapertussis infection, whereas there was a 3-fold increase in B. pertussis infection 
compared to uninfected controls.  This increase in CD11c+ cells may either be due to 
recruitment of DCs in the lungs during a state of infection or inability to leave the lungs 
and migrate to the lymph nodes, a phenomenon that could be attributed to PTx inhibition 
of chemokine receptors such as CCR7.  However, by 25 days post-infection, the percent 
CD11c+ cells in the lungs decreased for both infections, possibly due to a halt in 
recruitment of these cells to the lungs.   
In contrast to those who report partial DC maturation during B. pertussis infection 
(51), our results indicated that 5 days post-infection, lung DCs from B. pertussis infection 
had upregulated MHC class II, CD40 and CD86 and had generally higher levels of 
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maturation compared to that in B. parapertussis infection or uninfected controls.  This 
discrepancy between our results and those of others may be attributed to the timing of 
post-infection sampling or differences in bacterial strains.  The phenotype of DCs 
changed 25 days post-infection for B. parapertussis so that MHC class II, CD86, CD11b, 
and CCR5 were downregulated compared to B. pertussis.  However MHC class II 
remained upregulated in B. pertussis, which may be due to continued antigen presentation 
to CD4+ T cells in the regional lymph nodes even at late stages of infection.  Together 
this information indicated that 5 days post-infection, B. pertussis does not prevent DCs 
from acquiring a mature phenotype that is required for imprinting CD4+ T cells.  
However, by 25 days after infection, B. parapertussis-infected lungs appeared to revert to 
steady-state conditions, which may not be the case for B. pertussis infection.  An 
important chemokine receptor, CCR7, is required for entry into lymph nodes (24).  In 
order to further characterize the migratory ability of B. pertussis-infected DCs, CCR7 
assessment will be included in future experiments.  
  Once the DC phenotype was established, isolated lung DCs were co-cultured 
with naïve splenocytes harvested from allogeneic mice, and imprinting of trafficking 
molecules on CD4+ T cells was analyzed.  CD11a and CD162 have been reported to be 
important for adhesion and retention of cells in the lungs (43, 45).  Interestingly, we 
found that on day 5 post-infection, both CD11a and CD162 were downregulated in B. 
pertussis infection but upregulated in B. parapertussis, which suggests that PTx has a 
role in suppressing these molecules during peak infection.  However, on day 25 post-
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infection, CD11a levels were elevated, suggesting that this marker is upregulated only at 
later stages of infection, perhaps after the effects of PTx have diminished.   
Bordetella pertussis also showed elevated levels of CD103 on day 5 post-
infection, while it was downregulated in B. parapertussis co-cultures.  CD103 has been 
shown to be involved in tissue retention of lymphocytes (42), and perhaps CD4+ T cells 
are retained in the tissue instead of migrating during B. pertussis infection.  There is also 
evidence that CXCR3 is important for CD4+ T cell recruitment to the airways (11) and 
both Bordetella infections showed decreased levels of CXCR3 on day 5 of infection, 
while B. pertussis infection continued to show downregulation on day 25.  This indicates 
that perhaps both species prevent initial T cell recruitment to the lung through this 
chemokine receptor. 
The results from this research project suggest that B. pertussis downregulates 
certain trafficking molecules during peak infection; however, at later stages of infection 
these molecules are upregulated.  Since B. pertussis is a prolonged respiratory disease, it 
is possible that imprinting of trafficking molecules on CD4+ T cells persists during later 
stages of infection, perhaps due to the decreased effects of PTx.  Our experiments 
indicate that the lung environment for B. parapertussis returned to a state of homeostasis 
25 days after infection, whereas this is not the case for B. pertussis infection.   
Further studies can also include additional trafficking molecules such as CLA, 
CCR9 and α4β7 due to their presence on T cells that traffic exclusively to the skin and 
gut respectively.  Therefore, low levels of these molecules may be observed on T cells 
that home to the respiratory system (30, 48, 52).  Additional experiments may include in 
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vitro infection of uninfected lung DCs pulsed with PTx, to assess the antigen specific 
response and imprinting of trafficking molecules that are PTx-dependent.  Antigen pulsed 
DCs could be co-cultured with naïve splenocytes to allow for imprinting, and results can 
be compared to in vivo experimental Bordetella infection.  In order to further confirm the 
role of PTx, an experimental infection with B. parapertussis complemented with soluble 
PTx could be included and compared to B. pertussis (18).  This information will increase 
our understanding of the pathogenesis of B. pertussis, and the role of PTx in preventing 
lymphocyte recruitment to the respiratory system through trafficking molecule 
modulation.  This line of research may identify the molecules responsible for the 
exclusive recruitment of CD4+ T cells to the airways, leading to a more efficacious 
vaccine design that targets trafficking molecules important in B. pertussis infection.   
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Conclusions 
 These experiments were designed to study the interactions between DCs and 
CD4+ T cells that lead to the imprinting of trafficking markers, which are especially 
important for respiratory illnesses such as B. pertussis.  The discovery of lung specific 
trafficking markers will aid in the development of improved vaccines that target the 
upregulation of such molecules and will enhance the clearance of respiratory pathogens.  
Our results from this research project indicated that DCs are activated and adopt a mature 
phenotype from B. pertussis infection on day 5, and that perhaps PTx interferes with the 
imprinting process, as observed by the downregulation of CD11a and CD162 on CD4+ T 
cells, which are important molecules for T cell retention in the lungs.  However, 25 days 
post-infection with B. pertussis there is continued elevated expression of MHC class II, 
CCR5, and CD11b in addition to upregulation of CD11a and CD49d, which could be due 
to the fading effects of PTx.  This suggests that B. pertussis may initially alter the DC 
imprinting process to avoid T cell recruitment to the lungs. 
 
Future directions 
In order to further investigate the effects B. pertussis has on the respiratory 
system, we plan to perform immunohistochemical analysis of lung sections from 
uninfected and Bordetella-infected mice.  These lung sections will illustrate the degree of 
inflammation and tissue damage inflicted by the bacteria compared to uninfected lungs.  
We will also include fluorescence tagged antibodies specific to T cells to determine 
whether these cells are recruited to the lungs.  In order to broaden our analysis of 
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lymphocyte trafficking we will also incorporate CD8+ T cells to observe whether PTx 
differentially imprints homing molecules on this cell type during infection.  
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APPENDIX A: TIME COURSE EXPERIMENT TO DETERMINE PEAK 
INFECTION 
 
 
Time Course Of Infection
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FIGURE 6.  A time course of infection shows the peak infection days for B. pertussis 
and B. parapertussis.  In order to determine the optimal day for peak infection, we 
administered 5x106 CFU per 20 µl by intranasal administration and performed a time 
course experiment with two Balb/c mice per time-point.  Lungs were harvested at each 
time-point, homogenized and plated on Bordet-Gengou blood plates.  By day 25 post-
infection, zero colonies of B. pertussis and B. parapertussis were recovered from lungs 
(data not shown).  Experiment and analysis was done by Nicole Tarlton.   
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APPENDIX B: SUPPLEMENTARY DATA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
FIGURE 7.  DCs mature in response to B. pertussis infection even with smaller doses of 
inoculum.  BALB/c mice were infected intranasally with 5x105 CFU in 20 µl and percent 
DCs were measured in each treatment at a peak infection time of 10 days (A).  Maturation 
markers (MHC class II, CD40, CD86) and lung-associated markers (CD11b, CD207) 
were also measured (B).  Bordetella pertussis-infected DCs were co-cultured with naïve 
splenocytes and levels of CCR5, CCR6, CD103, CD106, CD11a, CD162, CD49d, and 
CD49f were assessed (C).  All values for the co-cultures were normalized to uninfected 
controls (100%). 
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Trafficking Molecule Expression During Peak Infection
0
20
40
60
80
100
120
140
160
180
%
 
Ex
pr
es
sio
n
 
o
n
 
C
D
4 
C
el
ls
Uninfected 100 100 100 100 100 100 100 100
B. pertussis 16.6 55.2 53.0 159.7 85.7 68.8 62.7 73.1
CCR5 CCR6 CD103 CD106 CD11a CD162 CD49d CD49f
7C 
B. pertussis 
DC Maturation During Peak Infection
90
100
110
120
130
140
150
160
%
 
Ex
pr
es
sio
n
 
o
n
 
C
D
11
c+
 
C
el
ls
Uninfected 100 100 100 100 100
B. pertussis 109.3 150.9 144.8 128.2 110.7
MHCII CD11b CD40 CD86 CD207
B. pertussis 
7B 
  54 
 
 
 
 
APPENDIX B: SUPPLEMENTARY DATA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 8.  DCs mature in response to Bordetella and downregulation of homing 
molecules on CD4+ T cells was observed in B. pertussis co-cultures.  We assessed the 
percentage of CD11c+ cells in each treatment using quadrants that were placed according 
to positive controls (A).  DC maturation markers observed included MHC class II, CD40, 
CD80, CD86; myeloid and lung associated markers, CD11b, CD207 and migratory 
makers CD103, CCR5, CCR6, CCR7 (B).  After co-culturing, levels of the chemokine 
receptors CCR5, CCR6, CXCR3, and adhesion markers CD11a, CD29, CD49a, CD49d, 
CD106, and CD162 were measured (C).  All values were normalized to uninfected 
controls (100%). 
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FIGURE 9.  25 days post-infection, the pattern of trafficking markers changes compared 
to peak infection.  25 days after infection with Bordetella, levels of CCR5, CCR6, 
CD49f, and CD162 were measured on co-cultured CD4+ T cell.  All values were 
normalized to uninfected controls (100%). 
